ATE279928T1 - Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben - Google Patents

Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben

Info

Publication number
ATE279928T1
ATE279928T1 AT00954693T AT00954693T ATE279928T1 AT E279928 T1 ATE279928 T1 AT E279928T1 AT 00954693 T AT00954693 T AT 00954693T AT 00954693 T AT00954693 T AT 00954693T AT E279928 T1 ATE279928 T1 AT E279928T1
Authority
AT
Austria
Prior art keywords
biologically active
active agent
controlled release
production
same
Prior art date
Application number
AT00954693T
Other languages
English (en)
Inventor
Manja Ahola
Eija Saeilynoja
Jukka Salonen
Risto Penttinen
Antti Yli-Urpo
Original Assignee
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxid Oy filed Critical Bioxid Oy
Application granted granted Critical
Publication of ATE279928T1 publication Critical patent/ATE279928T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT00954693T 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben ATE279928T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI991806A FI19991806A (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
PCT/FI2000/000710 WO2001013924A1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof

Publications (1)

Publication Number Publication Date
ATE279928T1 true ATE279928T1 (de) 2004-11-15

Family

ID=8555195

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954693T ATE279928T1 (de) 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben

Country Status (11)

Country Link
US (1) US7112339B1 (de)
EP (1) EP1206268B1 (de)
JP (1) JP2003507427A (de)
AT (1) ATE279928T1 (de)
AU (1) AU6705400A (de)
CA (1) CA2379982A1 (de)
DE (1) DE60015151T2 (de)
DK (1) DK1206268T3 (de)
ES (1) ES2230141T3 (de)
FI (1) FI19991806A (de)
WO (1) WO2001013924A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
AU2002229823B2 (en) 2001-04-04 2007-02-15 Delsitech Oy Biodegradable carrier and method for preparation thereof
AU2003237185A1 (en) * 2002-05-07 2003-11-11 The Research Foundation Of State University Of New York A method to rapidly prepare and screen formulations and compositions containing same
DE10249874A1 (de) * 2002-10-25 2004-05-06 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Antiadhäsive Beschichtung zur Ausrüstung von Wundverbänden
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
US8110284B2 (en) 2003-07-31 2012-02-07 Sol-Gel Technologies Ltd. Microcapsules loaded with active ingredients and a method for their preparation
AU2005217169B2 (en) * 2004-02-27 2011-09-01 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived SiO2
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
WO2007015243A2 (en) 2005-08-02 2007-02-08 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
US10099194B2 (en) * 2011-03-18 2018-10-16 International Flavors & Fragrances Inc. Microcapsules produced from blended sol-gel precursors and method for producing the same
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
KR101070345B1 (ko) 2009-07-03 2011-10-06 서울대학교산학협력단 생체활성인자가 포함된 유무기 혼성 복합 코팅층, 생체 이식용 임플란트 및 그 제조방법
EP3613413A1 (de) * 2011-12-05 2020-02-26 Incept, LLC Medizinische organogelprozesse und -zusammensetzungen
EP2919903B1 (de) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Zusammensetzungen mit einem biologischen wirkstoff und einem nicht geordneten anorganischen oxid
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
JP3488965B2 (ja) * 1996-05-21 2004-01-19 日本山村硝子株式会社 ゾル−ゲル法による独立膜の製造方法
WO1997045367A1 (en) * 1996-05-29 1997-12-04 Orion-Yhtymä Oy Dissolvable oxides for biological applications
CA2359699C (en) * 1999-02-22 2009-08-11 Bioxid Oy Biodegradable ceramic fibres from silica sols

Also Published As

Publication number Publication date
DE60015151D1 (de) 2004-11-25
DE60015151T2 (de) 2006-02-16
WO2001013924A1 (en) 2001-03-01
EP1206268A1 (de) 2002-05-22
AU6705400A (en) 2001-03-19
ES2230141T3 (es) 2005-05-01
FI19991806A (fi) 2001-02-26
DK1206268T3 (da) 2005-01-10
JP2003507427A (ja) 2003-02-25
CA2379982A1 (en) 2001-03-01
EP1206268B1 (de) 2004-10-20
US7112339B1 (en) 2006-09-26
WO2001013924A8 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
ATE279928T1 (de) Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
MXPA04001741A (es) Telas dispersables en agua sensibles al ion, un metodo y el uso de las mismas.
WO2003022852A3 (en) Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
AU8841801A (en) Switchable tackiness coating compositions for ophthalmic implants
ATE477311T1 (de) Beschichtungszusammensetzung und verfahren
ATE268124T1 (de) Flüssige chitosan-enthaltende zusammensetzungen und verfahren zur herstellung und verwendung
EP1420787B8 (de) Ascomycin enthaltende ophthalmische zubereitungen
ES2142123T3 (es) Derivados de organosiloxanilo de alcanodiol-monovinil-eteres, proceso para su preparacion, su modificacion y su empleo como aditivos para barnices.
EE05091B1 (et) Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid
DE60030777D1 (de) Durch ein sol-gel verfahren hergestellte bioaktive silicafasern und zugehörige verfahren und anwendungen
DE60112330D1 (en) Pyrazolopyridinderivate
AU6362100A (en) Derivatized polyurethane compositions and methods of making
BRPI0511574A (pt) composição, método para depositar um poliéster de açúcar sobre um substrato, e, uso de uma composição
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1545605B8 (de) Zusammensetzung zur impfung
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
MXPA04003755A (es) Endoprotesis vasculares.
MY128232A (en) Bleaching composition of enhanced stability and a process for making such a composition
MXPA04003783A (es) Composiciones para pulir muebles.
DE60126918D1 (de) Dielektrische Keramikkomposition, Verfahren zur Herstellung eines Keramikkondensators, Verwendung eines keramischen Dielektrikums, und Keramikkondensator
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
WO2002070638A3 (en) Essential oil from.coleus forskohlii, production process and use as antimicrobial agent
DE60201074D1 (en) Pyrazolopyridinderivate
ATE442361T1 (de) Verfahren zur herstellung kristalliner formen von orlistat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206268

Country of ref document: EP

REN Ceased due to non-payment of the annual fee